Dr. Ruisi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
435 E 70th St
Apartment 11F
New York, NY 10021Phone+1 212-933-4627
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2008 - 2011- New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 2005 - 2008
Icahn School of Medicine at Mount SinaiClass of 2005
Certifications & Licensure
MA State Medical License 2018 - 2026
NJ State Medical License 2012 - 2025
NY State Medical License 2006 - 2025- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 13 citationsAvelumab in paediatric patients with refractory or relapsed solid tumours: dose-escalation results from an open-label, single-arm, phase 1/2 trial.David M Loeb, Ji Won Lee, Daniel A Morgenstern, Yvan Samson, Anne Uyttebroeck
Cancer Immunology, Immunotherapy. 2022-10-01 - 1 citationsLong-term avelumab in advanced non-small-cell lung cancer: summaries andanalyses from JAVELIN Solid Tumor.Borys Hrinczenko, Nicholas Iannotti, Sanjay Goel, David Spigel, Howard Safran
Future Oncology. 2022-04-01 - 12 citationsReduced expression of annexin A2 is associated with impaired cell surface fibrinolysis and venous thromboembolismHannah Fassel, Huigen Chen, Mary M. Ruisi, Neha Kumar, Maria T. DeSancho
Blood. 2021-04-22
Press Mentions
- Investigators Find New Cause of Inherited Predisposition to Blood ClotsMay 25th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
